Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: July 2020

Workgroups: Immunization and Infectious Diseases Workgroup

The Advisory Committee on Immunization Practices recommends the hepatitis A vaccine for:

  • Children ages 12 to 23 months  
  • Children and adolescents ages 2 to 18 years who haven’t previously been vaccinated
  • At-risk adults and adults who request protection, even if they do not have a risk factor 

The recommendations also offer guidance for these circumstances:

  • Vaccination before travel
  • Prevention of disease after exposure to hepatitis A
  • Prevention of hepatitis A in settings where services are provided to adults
  • Steps to take during outbreaks of hepatitis A
Read more about this resource

Objectives related to this resource (1)

Reduce the rate of hepatitis A — IID‑10
Getting worse

Suggested Citation

1.

Nelson NP, Weng MK, Hofmeister MG, et al. (2020). Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. Retrieved from https://www.cdc.gov/mmwr/volumes/69/rr/rr6905a1.htm